KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amgen (AMGN) Gross Margin (2016 - 2025)

Historic Gross Margin for Amgen (AMGN) over the last 17 years, with Q3 2025 value amounting to 67.75%.

  • Amgen's Gross Margin rose 66800.0% to 67.75% in Q3 2025 from the same period last year, while for Sep 2025 it was 66.16%, marking a year-over-year increase of 56800.0%. This contributed to the annual value of 61.53% for FY2024, which is 84900.0% down from last year.
  • As of Q3 2025, Amgen's Gross Margin stood at 67.75%, which was up 66800.0% from 67.2% recorded in Q2 2025.
  • Over the past 5 years, Amgen's Gross Margin peaked at 77.1% during Q2 2022, and registered a low of 57.03% during Q1 2024.
  • Over the past 5 years, Amgen's median Gross Margin value was 73.84% (recorded in 2023), while the average stood at 69.94%.
  • In the last 5 years, Amgen's Gross Margin tumbled by -148000bps in 2024 and then soared by 66800bps in 2025.
  • Quarter analysis of 5 years shows Amgen's Gross Margin stood at 74.91% in 2021, then fell by -1bps to 74.46% in 2022, then decreased by -17bps to 62.03% in 2023, then grew by 6bps to 65.75% in 2024, then increased by 3bps to 67.75% in 2025.
  • Its Gross Margin stands at 67.75% for Q3 2025, versus 67.2% for Q2 2025 and 63.58% for Q1 2025.